These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15679169)

  • 1. Recent uses of topological indices in the development of in silico ADMET models.
    Votano JR
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADMET in silico modelling: towards prediction paradise?
    van de Waterbeemd H; Gifford E
    Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
    Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
    J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of ADMET Properties.
    Norinder U; Bergström CA
    ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction of ADMET properties: how far have we come?
    Dearden JC
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
    van de Waterbeemd H
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates.
    Shen M; Xiao Y; Golbraikh A; Gombar VK; Tropsha A
    J Med Chem; 2003 Jul; 46(14):3013-20. PubMed ID: 12825940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three new consensus QSAR models for the prediction of Ames genotoxicity.
    Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
    Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayer's in silico ADMET platform: a journey of machine learning over the past two decades.
    Göller AH; Kuhnke L; Montanari F; Bonin A; Schneckener S; Ter Laak A; Wichard J; Lobell M; Hillisch A
    Drug Discov Today; 2020 Sep; 25(9):1702-1709. PubMed ID: 32652309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a set of simple, interpretable ADMET rules of thumb.
    Gleeson MP
    J Med Chem; 2008 Feb; 51(4):817-34. PubMed ID: 18232648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward in silico structure-based ADMET prediction in drug discovery.
    Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
    Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling ADMET.
    Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
    Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds.
    Yang Y; Engkvist O; Llinàs A; Chen H
    J Med Chem; 2012 Apr; 55(8):3667-77. PubMed ID: 22443161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building predictive ADMET models for early decisions in drug discovery.
    Penzotti JE; Landrum GA; Putta S
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties.
    Gupta RR; Gifford EM; Liston T; Waller CL; Hohman M; Bunin BA; Ekins S
    Drug Metab Dispos; 2010 Nov; 38(11):2083-90. PubMed ID: 20693417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of protein structures in overcoming ADMET-related issues of drug-like compounds.
    Stoll F; Göller AH; Hillisch A
    Drug Discov Today; 2011 Jun; 16(11-12):530-8. PubMed ID: 21554979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.